Table 2 The prevalence of MAFLD in different subgroups
Variable | Category | Fraction | Prevalence rates (95% CI) | p value |
|---|---|---|---|---|
Age (years) | < 50 | 145/731 | 19.8 (17.0–22.9) | < 0.001 |
≥ 50 | 1426/4646 | 30.7 (29.4–32.0) |  | |
Sex | Male | 555/2173 | 25.5 (23.7–27.4) | < 0.001 |
Female | 1016/3204 | 31.7 (30.1–33.3) |  | |
High school and above | No | 1259/4407 | 28.6 (27.2–29.9) | 0.030 |
Yes | 309/963 | 32.1 (29.1–35.1) |  | |
High-income | No | 638/2460 | 25.9 (24.2–27.7) | < 0.001 |
Yes | 900/2831 | 31.8 (30.1–33.5) |  | |
Menopause | No | 83/514 | 16.1 (13.1–19.6) | < 0.001 |
Yes | 932/2689 | 34.7 (32.9–36.5) |  | |
Hypertension | No | 457/2241 | 20.4 (18.7–22.1) | < 0.001 |
Yes | 1114/3136 | 35.5 (33.8–37.2) |  | |
T2DM | No | 1179/4547 | 25.9 (24.7–27.2) | < 0.001 |
Yes | 392/830 | 47.2 (43.8–50.7) |  | |
Metabolic dysregulation | No | 592/3475 | 17.0 (15.8–18.3) | < 0.001 |
Yes | 975/1888 | 51.6 (49.4–53.9) |  | |
Overweight/obesity | No | 149/1945 | 7.7 (6.5–8.9) | < 0.001 |
Yes | 1419/3419 | 41.5 (39.8–43.2) |  | |
Central obesity | No | 260/2362 | 11.0 (9.7–12.3) | < 0.001 |
Yes | 1307/3001 | 43.6 (41.8–45.3) |  | |
ALT abnormality | No | 1406/5063 | 27.8 (26.5–29.0) | < 0.001 |
Yes | 151/264 | 57.2 (51.0–63.2) |  | |
Hypertriglyceridemia | No | 690/3463 | 19.9 (18.6–21.3) | < 0.001 |
Yes | 867/1864 | 46.5 (44.2–48.8) |  | |
HDL-C abnormality | No | 824/3542 | 23.3 (21.9–24.7) | < 0.001 |
Yes | 733/1785 | 41.1 (38.8–43.4) |  | |
Hyperuricemia | No | 738/3349 | 22.0 (20.6–23.5) | < 0.001 |
Yes | 819/1978 | 41.4 (39.2–43.6) |  | |
High physical activity | No | 1178/3878 | 30.4 (28.9–31.9) | 0.002 |
Yes | 386/1484 | 26.0 (23.8–28.3) |  | |
Frequency of soups | < 1 per week | 584/1772 | 33.0 (30.8–35.2) | < 0.001 |
≥ 3 per week | 474/1475 | 32.1 (29.8–34.6) |  |